TOFACITINIB

TOFACITINIB was reported 13404 times

TOFACITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SYNOVIAL FLUID ANALYSIS 79 0.9080
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 5363 0.7478
2 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 476 0.7126
3 SWOLLEN JOINT COUNT INCREASED 2235 0.7002
4 RHEUMATOID FACTOR NEGATIVE 122 0.6971
5 RHEUMATOID FACTOR POSITIVE 3990 0.6901
6 RHEUMATIC FEVER 2959 0.6632
7 LUPUS VULGARIS 766 0.6079
8 DUODENAL ULCER PERFORATION 4418 0.5935
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 1160 0.5791
10 HEPATIC ENZYME 85 0.5705
11 C-REACTIVE PROTEIN 524 0.5653
12 HAND DEFORMITY 7145 0.5442
13 GRANULOMA SKIN 445 0.5420
14 SYNOVITIS 9538 0.5285
15 SWOLLEN JOINT COUNT 132 0.5280
16 PEMPHIGUS 6516 0.5207
17 RED BLOOD CELL SEDIMENTATION RATE 143 0.5125
18 C-REACTIVE PROTEIN ABNORMAL 3260 0.5077
19 FACET JOINT SYNDROME 1637 0.5023
20 X-RAY ABNORMAL 830 0.4637
21 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1054 0.4571
22 HELICOBACTER INFECTION 4659 0.4529
23 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 910 0.4388
24 DISLOCATION OF VERTEBRA 980 0.4293
25 GRIP STRENGTH 98 0.4279
26 MUSCLE INJURY 3376 0.4070
27 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2591 0.3986
28 ANTICIPATORY ANXIETY 108 0.3971
29 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 220 0.3922
30 JOINT LAXITY 116 0.3841
31 BONE EROSION 1305 0.3686
32 RETINITIS 629 0.3638
33 FOLLICULITIS 3765 0.3587
34 DISCOURAGEMENT 809 0.3457
35 HYPOCHOLESTEROLAEMIA 122 0.3456
36 PERICARDITIS 5574 0.3314
37 PERIPHERAL VENOUS DISEASE 1353 0.3310
38 SERONEGATIVE ARTHRITIS 375 0.3272
39 RHEUMATOID NODULE 883 0.3203
40 BLOOD PARATHYROID HORMONE DECREASED 473 0.3189
41 DRUG TOLERANCE DECREASED 842 0.2995
42 GLOSSODYNIA 6584 0.2938
43 SENSITIVITY TO WEATHER CHANGE 1522 0.2890
44 CONTRAINDICATED PRODUCT ADMINISTERED 8561 0.2825
45 SHORT STATURE 73 0.2786
46 INTESTINAL SEPSIS 73 0.2786
47 ANKLE ARTHROPLASTY 97 0.2672
48 SPINAL INSTABILITY 66 0.2598
49 ELBOW DEFORMITY 86 0.2486
50 JOINT RANGE OF MOTION DECREASED 3201 0.2384
51 PRESBYACUSIS 73 0.2370
52 SYNOVIAL DISORDER 106 0.2330
53 WRIST DEFORMITY 142 0.2309
54 WOUND 6349 0.2269
55 NECK DEFORMITY 95 0.2140
56 NODAL OSTEOARTHRITIS 68 0.2105
57 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2316 0.2091
58 RHEUMATOID LUNG 199 0.2084
59 GRIP STRENGTH DECREASED 1806 0.2050
60 SYSTEMIC LUPUS ERYTHEMATOSUS 7245 0.2039
61 PANNICULITIS 490 0.2023
62 OVERLAP SYNDROME 140 0.2000
63 STEROID DEPENDENCE 167 0.1902
64 BREAST CANCER STAGE III 1232 0.1900
65 JOINT DESTRUCTION 294 0.1889
66 LIP DRY 1674 0.1841
67 ONYCHOMADESIS 773 0.1840
68 IRRITABLE BOWEL SYNDROME 3912 0.1823
69 BURSITIS 2138 0.1760
70 PORPHYRIA ACUTE 250 0.1742
71 FINGER DEFORMITY 842 0.1736
72 RHEUMATOID ARTHRITIS 19208 0.1690
73 ARTHROPATHY 9382 0.1686
74 TENOSYNOVITIS STENOSANS 93 0.1670
75 ONYCHOMYCOSIS 733 0.1669
76 HYPERCHOLESTEROLAEMIA 1572 0.1626
77 FIBROMYALGIA 3840 0.1578
78 THERAPEUTIC PRODUCT EFFECT DECREASED 6919 0.1543
79 WOUND INFECTION 1670 0.1523
80 C-REACTIVE PROTEIN DECREASED 94 0.1440
81 CATARRH 129 0.1427
82 TUBERCULIN TEST POSITIVE 358 0.1413
83 TENOSYNOVITIS 387 0.1402
84 IMPAIRED HEALING 4484 0.1364
85 BLEPHAROSPASM 856 0.1358
86 AUTOIMMUNE DISORDER 1305 0.1338
87 FOOT DEFORMITY 1447 0.1304
88 ENTHESOPATHY 203 0.1297
89 LIVE BIRTH 1076 0.1285
90 BLOOD CHOLESTEROL INCREASED 5919 0.1268
91 DRUG INTOLERANCE 12020 0.1243
92 JOINT SWELLING 14808 0.1226
93 NAIL DISORDER 1035 0.1182
94 ARTHRODESIS 120 0.1179
95 HEPATIC ENZYME INCREASED 7981 0.1170
96 SYSTEMIC LUPUS ERYTHEMATOSUS RASH 92 0.1153
97 HIP ARTHROPLASTY 1704 0.1111
98 EXOSTOSIS 995 0.1089
99 LIVER INJURY 2669 0.1086
100 JOINT ARTHROPLASTY 194 0.1083
101 SOFT TISSUE DISORDER 120 0.1082
102 MUSCULOSKELETAL STIFFNESS 9457 0.1078
103 PULMONARY FIBROSIS 2049 0.1067
104 TREATMENT FAILURE 8796 0.1061
105 SCIATICA 1686 0.1057
106 PLEURAL THICKENING 72 0.1053
107 TYPE 2 DIABETES MELLITUS 3492 0.1036
108 INFUSION RELATED REACTION 6817 0.1027
109 DEATH NEONATAL 141 0.1013
110 KNEE ARTHROPLASTY 2129 0.1010
111 SWELLING 9450 0.1009
112 BONE CYST 94 0.1002
113 PSORIATIC ARTHROPATHY 4057 0.0999
114 OBESITY 1578 0.0989
115 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 231 0.0973
116 C-REACTIVE PROTEIN INCREASED 3490 0.0958
117 RHEUMATOID FACTOR INCREASED 104 0.0931
118 MATERNAL EXPOSURE TIMING UNSPECIFIED 347 0.0923
119 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4429 0.0921
120 DISCOMFORT 5609 0.0918
121 JOINT DISLOCATION 970 0.0917
122 JOINT STIFFNESS 2400 0.0914
123 OSTEOARTHRITIS 3861 0.0910
124 PRODUCT DOSE OMISSION IN ERROR 2566 0.0905
125 LOWER RESPIRATORY TRACT INFECTION 4069 0.0894
126 INFUSION SITE REACTION 266 0.0890
127 LOWER LIMB FRACTURE 1708 0.0888
128 SKIN NECROSIS 461 0.0888
129 GAIT INABILITY 2961 0.0885
130 WALKING AID USER 584 0.0885
131 PUSTULAR PSORIASIS 304 0.0884
132 LIVER FUNCTION TEST INCREASED 1894 0.0881
133 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6273 0.0881
134 POLYARTHRITIS 464 0.0879
135 INFLAMMATION 4456 0.0863
136 PRESCRIBED OVERDOSE 1669 0.0862
137 TEMPERATURE REGULATION DISORDER 188 0.0843
138 JOINT EFFUSION 579 0.0839
139 LUPUS-LIKE SYNDROME 761 0.0838
140 SCLERITIS 134 0.0836
141 DRUG TOLERANCE 417 0.0823
142 LIMB DEFORMITY 130 0.0818
143 BLOOD MAGNESIUM INCREASED 73 0.0809
144 SPINAL STENOSIS 331 0.0801
145 COELIAC DISEASE 786 0.0800
146 CONTRAST MEDIA ALLERGY 141 0.0769
147 BURNS SECOND DEGREE 134 0.0763
148 BLISTER 4287 0.0763
149 PLEURAL FIBROSIS 77 0.0756
150 STOMATITIS 4485 0.0739
151 MOBILITY DECREASED 5287 0.0735
152 BACK INJURY 792 0.0728
153 BONE SWELLING 70 0.0723
154 DACTYLITIS 71 0.0723
155 HERPES ZOSTER 4105 0.0714
156 SPONDYLITIS 258 0.0709
157 SYNOVIAL CYST 327 0.0707
158 LIPIDS INCREASED 140 0.0693
159 ALLERGY TO CHEMICALS 84 0.0674
160 FOOT OPERATION 324 0.0654
161 MUSCULOSKELETAL PAIN 3411 0.0650
162 CONDITION AGGRAVATED 19789 0.0650
163 PHYSICAL DECONDITIONING 167 0.0648
164 NODULE 844 0.0646
165 PERIPHERAL SWELLING 9954 0.0645
166 CREPITATIONS 192 0.0644
167 PRURITUS ALLERGIC 74 0.0634
168 PRODUCT LABEL CONFUSION 366 0.0627
169 EYE INJURY 190 0.0625
170 FINE MOTOR SKILL DYSFUNCTION 181 0.0625
171 INFLAMMATORY MARKER INCREASED 310 0.0625
172 TENDERNESS 650 0.0623
173 ABDOMINAL DISCOMFORT 10454 0.0623
174 SINUSITIS 6318 0.0616
175 ULCER HAEMORRHAGE 417 0.0616
176 JOINT LOCK 174 0.0612
177 NIGHT SWEATS 1958 0.0607
178 BREAST CANCER STAGE II 505 0.0606
179 JOINT CREPITATION 119 0.0599
180 PRESCRIBED UNDERDOSE 1195 0.0598
181 ALANINE AMINOTRANSFERASE ABNORMAL 126 0.0597
182 SHOULDER ARTHROPLASTY 158 0.0586
183 ORAL MUCOSAL EXFOLIATION 88 0.0581
184 SPINAL FUSION SURGERY 232 0.0571
185 ARTHRITIS 4477 0.0569
186 CHONDROPATHY 154 0.0568
187 CONGENITAL ANOMALY 435 0.0561
188 OBLITERATIVE BRONCHIOLITIS 73 0.0556
189 INFECTION 7949 0.0549
190 PRE-EXISTING CONDITION IMPROVED 342 0.0547
191 ILL-DEFINED DISORDER 3307 0.0544
192 OSTEOSCLEROSIS 84 0.0533
193 MATERNAL EXPOSURE DURING PREGNANCY 4704 0.0527
194 UPPER RESPIRATORY TRACT INFECTION 2431 0.0526
195 INVESTIGATION ABNORMAL 75 0.0522
196 JOINT WARMTH 65 0.0521
197 ROTATOR CUFF REPAIR 91 0.0519
198 GASTROINTESTINAL DISORDER 4638 0.0517
199 BLOOD CHOLESTEROL ABNORMAL 239 0.0517
200 RASH VESICULAR 250 0.0517
201 POST HERPETIC NEURALGIA 74 0.0515
202 ANKLE OPERATION 76 0.0514
203 CUSHINGOID 164 0.0510
204 IMMUNE SYSTEM DISORDER 659 0.0500
205 JOINT INJURY 1051 0.0492
206 LUNG DISORDER 2409 0.0491
207 HEPATIC ENZYME ABNORMAL 244 0.0489
208 DRUG EFFECT INCOMPLETE 1775 0.0488
209 NASOPHARYNGITIS 8991 0.0487
210 ALOPECIA 9491 0.0483
211 ARTHRALGIA 20062 0.0482
212 ULCER 752 0.0472
213 LIVER DISORDER 2087 0.0470
214 JOINT NOISE 92 0.0468
215 PRERENAL FAILURE 65 0.0461
216 VIRAL UPPER RESPIRATORY TRACT INFECTION 219 0.0460
217 THERAPY NON-RESPONDER 2060 0.0458
218 SLEEP DISORDER 3234 0.0458
219 SPINAL OPERATION 562 0.0456
220 IMMUNODEFICIENCY 673 0.0451
221 FREQUENT BOWEL MOVEMENTS 1213 0.0449
222 LATENT TUBERCULOSIS 94 0.0448
223 WHEEZING 2653 0.0447
224 HEPATIC CIRRHOSIS 838 0.0446
225 TRIGGER FINGER 182 0.0445
226 OSTEOPOROSIS 1829 0.0444
227 NEOPLASM SKIN 69 0.0444
228 HYPERSENSITIVITY 8233 0.0443
229 JUVENILE IDIOPATHIC ARTHRITIS 108 0.0441
230 INTENTIONAL PRODUCT USE ISSUE 3858 0.0440
231 INJURY 3066 0.0436
232 OSTEOPOROTIC FRACTURE 83 0.0433
233 OPHTHALMIC HERPES ZOSTER 78 0.0432
234 LIMB OPERATION 207 0.0431
235 NECK MASS 122 0.0431
236 DISABILITY 848 0.0428
237 PAIN 26135 0.0425
238 EAR INFECTION 1132 0.0425
239 BASAL CELL CARCINOMA 663 0.0425
240 ROAD TRAFFIC ACCIDENT 1777 0.0424
241 PNEUMONIA VIRAL 135 0.0423
242 PULMONARY TOXICITY 298 0.0421
243 TASTE DISORDER 844 0.0416
244 THERAPEUTIC PRODUCT EFFECT DELAYED 189 0.0414
245 FAECAL CALPROTECTIN INCREASED 131 0.0413
246 BACK DISORDER 670 0.0412
247 DEFORMITY 384 0.0410
248 IMMOBILE 179 0.0410
249 PLEURITIC PAIN 112 0.0405
250 ILLNESS 4170 0.0404
251 ORAL SURGERY 94 0.0401
252 HYPERCALCAEMIA 494 0.0400
253 NECK SURGERY 93 0.0399
254 MUSCULOSKELETAL DISORDER 751 0.0394
255 KNEE OPERATION 388 0.0394
256 APPARENT DEATH 142 0.0394
257 EXPOSURE TO SARS-COV-2 67 0.0394
258 CONTUSION 3777 0.0392
259 SHOULDER OPERATION 167 0.0390
260 GENERAL PHYSICAL HEALTH DETERIORATION 4488 0.0388
261 BRONCHIECTASIS 260 0.0386
262 ARTHRITIS INFECTIVE 179 0.0386
263 ADVERSE REACTION 511 0.0385
264 FEAR OF INJECTION 272 0.0381
265 OEDEMA 2058 0.0379
266 HYPOPNOEA 131 0.0377
267 TOOTH INFECTION 496 0.0376
268 NECK PAIN 2081 0.0372
269 NORMAL NEWBORN 202 0.0371
270 HYPOACUSIS 1599 0.0371
271 DERMATOMYOSITIS 94 0.0371
272 GASTROINTESTINAL TOXICITY 176 0.0366
273 HIP SURGERY 197 0.0364
274 ACNE CYSTIC 109 0.0362
275 MEAN CELL HAEMOGLOBIN DECREASED 66 0.0360
276 DRY MOUTH 2920 0.0360
277 SUSPECTED COVID-19 118 0.0357
278 COLITIS ULCERATIVE 1598 0.0357
279 DIVERTICULITIS 987 0.0356
280 PAIN IN EXTREMITY 10467 0.0355
281 DECREASED IMMUNE RESPONSIVENESS 348 0.0354
282 SKIN PAPILLOMA 142 0.0354
283 ANTINUCLEAR ANTIBODY POSITIVE 115 0.0354
284 RHEUMATIC DISORDER 67 0.0346
285 SKIN ULCER 889 0.0344
286 MUCOUS STOOLS 170 0.0343
287 PRODUCT PRESCRIBING ERROR 816 0.0342
288 DRUG INEFFECTIVE 43969 0.0333
289 GASTRIC DISORDER 1137 0.0331
290 IMMUNOSUPPRESSION 291 0.0330
291 PRODUCT USE ISSUE 6192 0.0329
292 EPIGASTRIC DISCOMFORT 128 0.0327
293 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 560 0.0326
294 FOOD ALLERGY 252 0.0326
295 INFECTION SUSCEPTIBILITY INCREASED 71 0.0324
296 DRUG-INDUCED LIVER INJURY 1002 0.0319
297 DRUG ERUPTION 564 0.0318
298 BOWEL MOVEMENT IRREGULARITY 243 0.0317
299 MEMORY IMPAIRMENT 4359 0.0317
300 BONE DENSITY ABNORMAL 118 0.0315
301 INTENTIONAL DOSE OMISSION 898 0.0315
302 WHEELCHAIR USER 140 0.0315
303 THERAPEUTIC RESPONSE UNEXPECTED 1408 0.0314
304 BRONCHITIS 2315 0.0312
305 CARPAL TUNNEL SYNDROME 438 0.0312
306 BRONCHITIS CHRONIC 76 0.0311
307 MYOSITIS 278 0.0310
308 IMPAIRED WORK ABILITY 661 0.0309
309 LOSS OF EMPLOYMENT 93 0.0308
310 MUSCULOSKELETAL DISCOMFORT 530 0.0308
311 PREGNANCY 616 0.0307
312 CHANGE OF BOWEL HABIT 63 0.0307
313 LIMB DISCOMFORT 946 0.0305
314 TONGUE DISORDER 221 0.0305
315 EXPOSURE DURING PREGNANCY 1896 0.0305
316 EAR PAIN 593 0.0305
317 LOCALISED INFECTION 737 0.0304
318 HYPERTENSION 6430 0.0303
319 ALCOHOL POISONING 81 0.0302
320 COVID-19 5295 0.0301
321 HEPATITIS 765 0.0299
322 FOETAL DEATH 155 0.0299
323 SINUS DISORDER 588 0.0297
324 INTENTIONAL PRODUCT MISUSE 2594 0.0296
325 GASTROENTERITIS VIRAL 534 0.0295
326 DEMYELINATION 121 0.0295
327 DYSPEPSIA 2902 0.0295
328 BODY HEIGHT DECREASED 313 0.0292
329 TOOTH ABSCESS 297 0.0291
330 HYPOAESTHESIA 4364 0.0291
331 DYSGRAPHIA 192 0.0291
332 PULMONARY THROMBOSIS 317 0.0290
333 WEIGHT INCREASED 6499 0.0290
334 COLITIS MICROSCOPIC 137 0.0289
335 UPPER RESPIRATORY TRACT CONGESTION 83 0.0286
336 PELVIC FRACTURE 223 0.0286
337 HAIR GROWTH ABNORMAL 198 0.0286
338 ARTHRITIS BACTERIAL 117 0.0285
339 DELIRIUM 984 0.0283
340 FUNGAL SKIN INFECTION 114 0.0282
341 RASH 12289 0.0282
342 HEPATIC FIBROSIS 96 0.0279
343 NERVE COMPRESSION 258 0.0279
344 FRUSTRATION TOLERANCE DECREASED 224 0.0277
345 URINARY TRACT INFECTION BACTERIAL 70 0.0277
346 EPILEPSY 839 0.0274
347 CONFUSIONAL STATE 4413 0.0273
348 FOOT FRACTURE 517 0.0272
349 PHARYNGITIS 337 0.0271
350 CUTANEOUS VASCULITIS 99 0.0271
351 HEPATIC STEATOSIS 505 0.0271
352 MIGRAINE 2582 0.0270
353 BREATH SOUNDS ABNORMAL 133 0.0269
354 INFLUENZA 3001 0.0269
355 BONE DISORDER 489 0.0268
356 GENERAL SYMPTOM 201 0.0268
357 ROSACEA 124 0.0266
358 RHINORRHOEA 1698 0.0262
359 DEPRESSED MOOD 1388 0.0262
360 KIDNEY INFECTION 513 0.0261
361 HEPATOTOXICITY 580 0.0260
362 GINGIVAL PAIN 207 0.0260
363 CARTILAGE INJURY 64 0.0259
364 SARCOIDOSIS 123 0.0259
365 HAEMATOCHEZIA 1428 0.0258
366 DRUG EFFECT DECREASED 1382 0.0256
367 PRODUCT RESIDUE PRESENT 138 0.0256
368 RESPIRATORY DISORDER 765 0.0255
369 DENTAL OPERATION 63 0.0255
370 GAIT DISTURBANCE 4885 0.0255
371 BLOOD PRESSURE SYSTOLIC ABNORMAL 63 0.0255
372 POST PROCEDURAL INFECTION 207 0.0254
373 BLOOD PRESSURE ABNORMAL 500 0.0251
374 MENISCUS INJURY 153 0.0249
375 MOUTH ULCERATION 519 0.0246
376 SEASONAL ALLERGY 348 0.0246
377 SKIN CANCER 529 0.0245
378 MALAISE 10773 0.0245
379 ONYCHOCLASIS 169 0.0245
380 ABDOMINAL PAIN UPPER 5049 0.0245
381 DEFAECATION URGENCY 171 0.0244
382 NASAL CONGESTION 1429 0.0243
383 PARANASAL SINUS DISCOMFORT 92 0.0243
384 LYME DISEASE 81 0.0243
385 MAJOR DEPRESSION 177 0.0242
386 RED CELL DISTRIBUTION WIDTH INCREASED 100 0.0240
387 CYSTITIS 766 0.0240
388 LIMB INJURY 651 0.0239
389 TENDONITIS 371 0.0239
390 MOVEMENT DISORDER 768 0.0239
391 EYE INFECTION 270 0.0239
392 SUSPECTED OFF LABEL USE 108 0.0239
393 ADVERSE DRUG REACTION 2138 0.0238
394 ANIMAL BITE 63 0.0236
395 ORAL INFECTION 92 0.0235
396 DEAFNESS NEUROSENSORY 77 0.0234
397 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 682 0.0233
398 NERVE INJURY 258 0.0232
399 PHYSICAL DISABILITY 102 0.0231
400 RHINITIS 186 0.0230
401 NEAR DEATH EXPERIENCE 76 0.0230
402 CHRONIC SINUSITIS 86 0.0229
403 SPINAL DISORDER 216 0.0228
404 INCREASED TENDENCY TO BRUISE 209 0.0227
405 THERAPEUTIC RESPONSE DECREASED 1359 0.0224
406 CYST 277 0.0223
407 URTICARIA 3727 0.0222
408 DRUG USE DISORDER 187 0.0222
409 OROPHARYNGEAL PAIN 2057 0.0222
410 PHARYNGITIS STREPTOCOCCAL 240 0.0222
411 GLAUCOMA 425 0.0220
412 INTERVERTEBRAL DISC DISORDER 94 0.0220
413 ORAL HERPES 429 0.0220
414 CATARACT 1307 0.0219
415 HEADACHE 13701 0.0218
416 FURUNCLE 173 0.0218
417 MUSCLE RUPTURE 85 0.0218
418 FATIGUE 16945 0.0217
419 RECTAL HAEMORRHAGE 934 0.0217
420 ADRENAL INSUFFICIENCY 263 0.0217
421 ADVERSE EVENT 1994 0.0216
422 EAR DISORDER 99 0.0216
423 ANKLE FRACTURE 333 0.0215
424 SPINAL PAIN 252 0.0215
425 BLOOD TEST ABNORMAL 302 0.0215
426 SINUS CONGESTION 289 0.0214
427 RENAL FUNCTION TEST ABNORMAL 99 0.0213
428 HERNIA 410 0.0212
429 SKIN INFECTION 237 0.0211
430 POLYP 138 0.0211
431 GASTROOESOPHAGEAL REFLUX DISEASE 1694 0.0210
432 GASTRIC INFECTION 80 0.0209
433 SKIN LESION 573 0.0209
434 URINARY TRACT INFECTION 3550 0.0208
435 UPPER LIMB FRACTURE 414 0.0208
436 TOOTHACHE 374 0.0206
437 FEMUR FRACTURE 639 0.0206
438 LIVER FUNCTION TEST ABNORMAL 599 0.0206
439 INTERVERTEBRAL DISC PROTRUSION 450 0.0206
440 WEIGHT FLUCTUATION 214 0.0204
441 EYE OPERATION 94 0.0204
442 INTERSTITIAL LUNG DISEASE 983 0.0203
443 PLANTAR FASCIITIS 68 0.0203
444 LYMPHOMA 312 0.0202
445 AMNESIA 1313 0.0202
446 INJECTION SITE HYPERSENSITIVITY 63 0.0201
447 RESPIRATORY TRACT CONGESTION 320 0.0201
448 VITAMIN D DECREASED 171 0.0200
449 APHONIA 279 0.0200
450 VIRAL INFECTION 665 0.0200
451 PRODUCT DOSE OMISSION ISSUE 5860 0.0199
452 INTERVERTEBRAL DISC DEGENERATION 184 0.0199
453 DRY EYE 988 0.0198
454 TENDON DISORDER 129 0.0198
455 PNEUMONIA 6371 0.0197
456 COLECTOMY 111 0.0196
457 GRANULOMA 68 0.0196
458 LOW DENSITY LIPOPROTEIN INCREASED 151 0.0195
459 PAROSMIA 147 0.0195
460 TERMINAL STATE 130 0.0194
461 RESPIRATORY TRACT INFECTION 505 0.0194
462 ANKYLOSING SPONDYLITIS 255 0.0193
463 LIGAMENT SPRAIN 191 0.0193
464 IMPAIRED QUALITY OF LIFE 276 0.0192
465 EYE DISORDER 629 0.0191
466 THYROID DISORDER 294 0.0191
467 LIGAMENT RUPTURE 84 0.0190
468 HERPES VIRUS INFECTION 109 0.0189
469 ROTATOR CUFF SYNDROME 243 0.0189
470 TOOTH FRACTURE 208 0.0188
471 SPINAL COLUMN STENOSIS 89 0.0188
472 BLOOD IRON DECREASED 223 0.0188
473 TOOTH DISORDER 416 0.0187
474 GROIN PAIN 164 0.0187
475 LABORATORY TEST ABNORMAL 550 0.0186
476 SKIN MASS 124 0.0186
477 OSTEOPENIA 281 0.0185
478 MUSCULAR WEAKNESS 2104 0.0185
479 ORAL DISCOMFORT 257 0.0185
480 NEPHROLITHIASIS 842 0.0183
481 GOITRE 75 0.0183
482 FUNGAL INFECTION 610 0.0183
483 MALIGNANT MELANOMA 245 0.0183
484 OROPHARYNGEAL DISCOMFORT 165 0.0182
485 CARDIAC MURMUR 158 0.0182
486 SKIN LACERATION 198 0.0182
487 BEDRIDDEN 239 0.0182
488 ASTHMA 2054 0.0182
489 GINGIVITIS 98 0.0182
490 SPINAL FRACTURE 359 0.0179
491 HYPOKINESIA 260 0.0179
492 PRODUCT DOSE OMISSION 1162 0.0178
493 NEOPLASM MALIGNANT 1183 0.0177
494 PAIN IN JAW 501 0.0177
495 BLOOD PRESSURE DIASTOLIC INCREASED 81 0.0175
496 INJECTION SITE REACTION 1201 0.0174
497 OFF LABEL USE 15236 0.0174
498 THERAPY INTERRUPTED 1242 0.0174
499 MUSCLE SPASMS 3187 0.0173
500 PYREXIA 5994 0.0173
501 WRIST FRACTURE 207 0.0173
502 OSTEOMYELITIS 312 0.0172
503 RASH PRURITIC 931 0.0172
504 DEPRESSION 3899 0.0171
505 DEAFNESS 448 0.0171
506 GASTROINTESTINAL PERFORATION 71 0.0171
507 CEREBRAL DISORDER 126 0.0170
508 MUSCLE STRAIN 147 0.0170
509 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 929 0.0169
510 ACCIDENT 201 0.0168
511 IRON DEFICIENCY ANAEMIA 155 0.0168
512 PARANASAL SINUS HYPERSECRETION 64 0.0168
513 INCORRECT DOSAGE ADMINISTERED 82 0.0168
514 SKIN DISORDER 559 0.0167
515 DIVERTICULUM 119 0.0167
516 ABDOMINAL TENDERNESS 83 0.0167
517 PSORIASIS 2169 0.0166
518 VISUAL IMPAIRMENT 2056 0.0166
519 SKIN REACTION 233 0.0165
520 SECRETION DISCHARGE 207 0.0165
521 PULMONARY MASS 246 0.0165
522 SINUS HEADACHE 98 0.0165
523 STRESS FRACTURE 89 0.0165
524 BACK PAIN 3824 0.0164
525 TENDON RUPTURE 202 0.0163
526 DRUG EFFECT DELAYED 74 0.0163
527 ORAL DISORDER 119 0.0162
528 POSTOPERATIVE WOUND INFECTION 109 0.0161
529 INFLAMMATORY BOWEL DISEASE 157 0.0160
530 PARAESTHESIA 2514 0.0160
531 DERMATITIS ALLERGIC 201 0.0160
532 INSOMNIA 4237 0.0159
533 COVID-19 PNEUMONIA 187 0.0158
534 MUSCLE FATIGUE 67 0.0158
535 THROMBOSIS 1269 0.0158
536 CHEST PAIN 2919 0.0157
537 FOOD POISONING 84 0.0157
538 PHOTOSENSITIVITY REACTION 259 0.0157
539 FLUID RETENTION 791 0.0155
540 URINARY TRACT DISORDER 70 0.0155
541 SPINAL COMPRESSION FRACTURE 128 0.0155
542 DIARRHOEA 9964 0.0154
543 BRADYKINESIA 90 0.0152
544 RIB FRACTURE 313 0.0152
545 DRUG EFFECT LESS THAN EXPECTED 225 0.0152
546 DIABETES MELLITUS 1154 0.0151
547 TIBIA FRACTURE 71 0.0151
548 ENERGY INCREASED 89 0.0151
549 DYSSTASIA 440 0.0151
550 COUGH 4199 0.0150
551 FLANK PAIN 140 0.0149
552 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 112 0.0149
553 DISEASE RECURRENCE 706 0.0148
554 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 252 0.0148
555 CORONAVIRUS INFECTION 98 0.0148
556 CANDIDA INFECTION 250 0.0148
557 SPINAL OSTEOARTHRITIS 130 0.0148
558 MULTIPLE ALLERGIES 116 0.0148
559 VAGINAL INFECTION 69 0.0146
560 HIP FRACTURE 469 0.0146
561 MEDICATION ERROR 809 0.0145
562 UVEITIS 197 0.0145
563 CLOSTRIDIUM DIFFICILE INFECTION 316 0.0145
564 UPPER-AIRWAY COUGH SYNDROME 119 0.0144
565 SQUAMOUS CELL CARCINOMA OF SKIN 87 0.0144
566 LUNG INFECTION 223 0.0143
567 ABNORMAL FAECES 117 0.0143
568 CATARACT OPERATION 84 0.0141
569 LEUKOPENIA 702 0.0140
570 STREPTOCOCCAL INFECTION 78 0.0140
571 PRODUCT USE IN UNAPPROVED INDICATION 3465 0.0140
572 ALANINE AMINOTRANSFERASE INCREASED 858 0.0140
573 APHTHOUS ULCER 108 0.0139
574 FRACTURE 262 0.0138
575 HAND FRACTURE 98 0.0138
576 MASS 193 0.0138
577 PLEURISY 82 0.0138
578 DIARRHOEA HAEMORRHAGIC 129 0.0138
579 ANAL ABSCESS 74 0.0137
580 LARGE INTESTINE POLYP 95 0.0137
581 FALL 4552 0.0137
582 ARTHROPOD BITE 101 0.0136
583 SKIN ATROPHY 78 0.0135
584 RENAL DISORDER 629 0.0135
585 BLOOD PRESSURE SYSTOLIC INCREASED 263 0.0135
586 POOR QUALITY SLEEP 290 0.0135
587 DECREASED APPETITE 3122 0.0134
588 TOE AMPUTATION 68 0.0134
589 OEDEMA PERIPHERAL 1627 0.0133
590 ORAL PAIN 298 0.0133
591 GASTROINTESTINAL INFECTION 119 0.0133
592 TOOTH EXTRACTION 165 0.0132
593 PRURITUS 5065 0.0132
594 ACNE 998 0.0131
595 CELLULITIS 663 0.0131
596 ASPARTATE AMINOTRANSFERASE INCREASED 698 0.0131
597 ANAPHYLACTIC REACTION 721 0.0130
598 MULTIPLE FRACTURES 214 0.0130
599 WHITE BLOOD CELL COUNT INCREASED 499 0.0130
600 VEIN DISORDER 65 0.0130
601 HYPERTRANSAMINASAEMIA 90 0.0129
602 BLOOD PRESSURE INCREASED 1975 0.0129
603 NAUSEA 10213 0.0129
604 ABDOMINAL PAIN 2990 0.0128
605 OVERWEIGHT 69 0.0128
606 VITAMIN D DEFICIENCY 125 0.0128
607 RED BLOOD CELL COUNT DECREASED 366 0.0128
608 ABDOMINAL DISTENSION 1321 0.0126
609 NEURALGIA 307 0.0126
610 COLITIS 478 0.0126
611 CARDIAC OPERATION 108 0.0126
612 BREAST MASS 84 0.0125
613 DRY THROAT 127 0.0125
614 STAPHYLOCOCCAL INFECTION 411 0.0124
615 DEMENTIA 348 0.0124
616 SQUAMOUS CELL CARCINOMA 117 0.0124
617 MUSCULOSKELETAL CHEST PAIN 192 0.0124
618 MUSCLE SPASTICITY 152 0.0124
619 PULMONARY CONGESTION 163 0.0124
620 HYSTERECTOMY 107 0.0123
621 SCOLIOSIS 76 0.0123
622 LARGE INTESTINE PERFORATION 85 0.0122
623 THERAPY CESSATION 628 0.0122
624 GOUT 219 0.0122
625 SARS-COV-2 TEST POSITIVE 161 0.0122
626 FEELING ABNORMAL 2919 0.0122
627 PNEUMOCYSTIS JIROVECII PNEUMONIA 122 0.0121
628 FAECES SOFT 88 0.0121
629 DEEP VEIN THROMBOSIS 784 0.0121
630 VOMITING 5670 0.0120
631 GASTROINTESTINAL PAIN 131 0.0119
632 MACULAR DEGENERATION 142 0.0119
633 BLOOD TRIGLYCERIDES INCREASED 210 0.0119
634 IMPAIRED GASTRIC EMPTYING 162 0.0119
635 LYMPHOEDEMA 82 0.0118
636 ATELECTASIS 114 0.0118
637 EAR DISCOMFORT 121 0.0118
638 URINE ODOUR ABNORMAL 69 0.0117
639 MIDDLE INSOMNIA 219 0.0117
640 DYSPNOEA 6615 0.0117
641 PLATELET COUNT INCREASED 152 0.0116
642 FACIAL PAIN 104 0.0116
643 PRODUCT PRESCRIBING ISSUE 253 0.0116
644 VASCULITIS 135 0.0116
645 FEELING HOT 706 0.0115
646 GASTRIC ULCER 218 0.0115
647 PRODUCTIVE COUGH 547 0.0114
648 CONCUSSION 88 0.0114
649 CONJUNCTIVITIS 209 0.0113
650 ENTERITIS 72 0.0112
651 MUSCLE DISORDER 91 0.0112
652 ASTHENIA 4217 0.0112
653 COLON CANCER 167 0.0112
654 EMPHYSEMA 112 0.0111
655 BLINDNESS 452 0.0111
656 WEIGHT DECREASED 3067 0.0110
657 PULMONARY EMBOLISM 1042 0.0110
658 DYSPHONIA 634 0.0108
659 GLUCOSE TOLERANCE IMPAIRED 64 0.0108
660 HIATUS HERNIA 139 0.0107
661 DERMATITIS ACNEIFORM 65 0.0107
662 HAEMORRHOIDS 208 0.0107
663 TEMPERATURE INTOLERANCE 110 0.0106
664 HERPES SIMPLEX 69 0.0106
665 BACTERIAL INFECTION 198 0.0106
666 ORAL CANDIDIASIS 139 0.0105
667 LYMPHADENOPATHY 370 0.0104
668 POLLAKIURIA 435 0.0104
669 NASAL DISCOMFORT 82 0.0103
670 ANAL INCONTINENCE 93 0.0103
671 BLOOD PRESSURE FLUCTUATION 248 0.0103
672 MENINGITIS 69 0.0103
673 QUALITY OF LIFE DECREASED 138 0.0103
674 DIZZINESS 5126 0.0103
675 RESPIRATORY SYNCYTIAL VIRUS INFECTION 89 0.0102
676 HYPERLIPIDAEMIA 122 0.0102
677 FLATULENCE 576 0.0101
678 BLOOD DISORDER 81 0.0101
679 MOTOR DYSFUNCTION 103 0.0101
680 CHOLECYSTECTOMY 115 0.0101
681 HUNGER 140 0.0100
682 HAEMATOCRIT DECREASED 198 0.0100
683 PANCREATITIS 522 0.0099
684 ABSCESS 157 0.0098
685 PERIPHERAL COLDNESS 135 0.0098
686 BRAIN FOG 154 0.0098
687 PRODUCT DISPENSING ERROR 213 0.0098
688 MYALGIA 1657 0.0097
689 DRUG SPECIFIC ANTIBODY PRESENT 63 0.0097
690 PNEUMONIA BACTERIAL 88 0.0096
691 DENTAL CARIES 106 0.0096
692 BODY TEMPERATURE DECREASED 94 0.0095
693 BLOOD PRESSURE DIASTOLIC DECREASED 70 0.0095
694 THINKING ABNORMAL 175 0.0094
695 SPUTUM DISCOLOURED 89 0.0094
696 GALLBLADDER DISORDER 167 0.0093
697 INFLUENZA LIKE ILLNESS 761 0.0092
698 ESCHERICHIA INFECTION 76 0.0092
699 CARDIAC DISORDER 864 0.0092
700 TINNITUS 424 0.0092
701 BONE PAIN 540 0.0092
702 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 480 0.0092
703 SNEEZING 206 0.0092
704 RENAL PAIN 97 0.0091
705 WHITE BLOOD CELL COUNT DECREASED 991 0.0091
706 GLOMERULAR FILTRATION RATE DECREASED 112 0.0091
707 RENAL IMPAIRMENT 763 0.0091
708 GINGIVAL BLEEDING 124 0.0091
709 GASTROINTESTINAL INFLAMMATION 71 0.0091
710 UNDERDOSE 661 0.0090
711 ANXIETY 2565 0.0090
712 PHARYNGEAL SWELLING 88 0.0090
713 APPENDICITIS 84 0.0090
714 HYPOCALCAEMIA 170 0.0090
715 BLADDER DISORDER 89 0.0090
716 ACTIVITIES OF DAILY LIVING IMPAIRED 177 0.0089
717 SWOLLEN TONGUE 278 0.0089
718 BLOOD CREATININE INCREASED 578 0.0088
719 TRANSAMINASES INCREASED 195 0.0088
720 LUNG NEOPLASM MALIGNANT 358 0.0087
721 SCAR 149 0.0087
722 SEROTONIN SYNDROME 167 0.0087
723 FACIAL PARALYSIS 74 0.0087
724 FEEDING DISORDER 176 0.0087
725 VERTIGO 527 0.0086
726 POST PROCEDURAL COMPLICATION 166 0.0086
727 INCREASED APPETITE 165 0.0086
728 PHOTOPHOBIA 162 0.0086
729 INTESTINAL PERFORATION 96 0.0085
730 TENDON PAIN 64 0.0084
731 STENT PLACEMENT 68 0.0084
732 EYE HAEMORRHAGE 112 0.0084
733 UROSEPSIS 77 0.0083
734 NEOPLASM 95 0.0083
735 SKIN DISCOLOURATION 378 0.0082
736 PHARYNGEAL OEDEMA 126 0.0082
737 BRAIN NEOPLASM 75 0.0082
738 BODY TEMPERATURE INCREASED 166 0.0081
739 CONSTIPATION 1773 0.0081
740 BONE DENSITY DECREASED 254 0.0081
741 SWELLING FACE 527 0.0081
742 BURNING SENSATION 566 0.0081
743 MICTURITION URGENCY 92 0.0080
744 LEUKAEMIA 76 0.0080
745 GASTRITIS 208 0.0079
746 EYE INFLAMMATION 75 0.0079
747 DECUBITUS ULCER 64 0.0078
748 ERYTHEMA 1611 0.0078
749 THROAT IRRITATION 351 0.0078
750 GASTROENTERITIS 114 0.0078
751 SPEECH DISORDER 408 0.0078
752 SURGERY 456 0.0078
753 DYSURIA 286 0.0078
754 FEELING JITTERY 148 0.0078
755 RASH ERYTHEMATOUS 371 0.0078
756 HAEMOGLOBIN DECREASED 796 0.0077
757 NEUTROPHIL COUNT INCREASED 79 0.0077
758 IMPAIRED DRIVING ABILITY 87 0.0076
759 CEREBROVASCULAR ACCIDENT 1290 0.0076
760 BLOOD POTASSIUM INCREASED 123 0.0076
761 CLOSTRIDIUM DIFFICILE COLITIS 80 0.0075
762 SCAB 86 0.0075
763 MENTAL IMPAIRMENT 182 0.0075
764 SEPSIS 836 0.0075
765 LYMPHOCYTE COUNT DECREASED 131 0.0074
766 PARALYSIS 106 0.0074
767 EATING DISORDER 156 0.0073
768 DECREASED ACTIVITY 79 0.0073
769 TOOTH LOSS 151 0.0073
770 PNEUMONITIS 196 0.0072
771 CHILLS 841 0.0072
772 HYPERHIDROSIS 922 0.0071
773 NERVOUSNESS 373 0.0071
774 BLOOD COUNT ABNORMAL 108 0.0071
775 NEUROPATHY PERIPHERAL 676 0.0071
776 FULL BLOOD COUNT ABNORMAL 75 0.0071
777 HEAD INJURY 223 0.0070
778 HYPOTHYROIDISM 225 0.0070
779 MUSCLE ATROPHY 89 0.0070
780 CYTOPENIA 85 0.0069
781 HOT FLUSH 523 0.0069
782 HEART RATE IRREGULAR 156 0.0069
783 HEAD DISCOMFORT 122 0.0069
784 SEPTIC SHOCK 297 0.0068
785 DERMATITIS 143 0.0068
786 MUSCLE TIGHTNESS 110 0.0068
787 ANAEMIA 1294 0.0068
788 TUBULOINTERSTITIAL NEPHRITIS 127 0.0068
789 GASTRIC HAEMORRHAGE 76 0.0066
790 BLOOD URINE PRESENT 125 0.0066
791 MYOCARDIAL INFARCTION 1146 0.0066
792 THYROID CANCER 79 0.0066
793 ATRIAL FIBRILLATION 639 0.0066
794 LOSS OF CONSCIOUSNESS 833 0.0065
795 EMOTIONAL DISORDER 199 0.0064
796 HYPERTENSIVE CRISIS 71 0.0064
797 FAECES DISCOLOURED 138 0.0064
798 CHOLELITHIASIS 207 0.0063
799 PALPITATIONS 739 0.0063
800 RASH MACULAR 218 0.0062
801 HAEMORRHAGE 649 0.0062
802 SKIN HAEMORRHAGE 92 0.0062
803 EYE DISCHARGE 64 0.0062
804 TACHYCARDIA 544 0.0061
805 LOCAL SWELLING 106 0.0061
806 RASH PAPULAR 136 0.0061
807 PLEURAL EFFUSION 368 0.0060
808 HYPOKALAEMIA 279 0.0060
809 ACCIDENTAL OVERDOSE 221 0.0060
810 BLINDNESS UNILATERAL 85 0.0060
811 BREAST PAIN 64 0.0060
812 FEELING COLD 167 0.0060
813 MENTAL DISORDER 261 0.0060
814 HEART RATE INCREASED 594 0.0060
815 CRYING 217 0.0060
816 DRUG RESISTANCE 153 0.0060
817 THROMBOCYTOPENIA 666 0.0059
818 EPISTAXIS 445 0.0059
819 RASH MACULO-PAPULAR 132 0.0059
820 SLEEP APNOEA SYNDROME 113 0.0059
821 DEVICE RELATED INFECTION 91 0.0059
822 OESOPHAGITIS 64 0.0059
823 PRODUCT QUALITY ISSUE 786 0.0058
824 NERVOUS SYSTEM DISORDER 180 0.0058
825 RESTLESS LEGS SYNDROME 104 0.0057
826 ECZEMA 297 0.0057
827 CHOKING 110 0.0056
828 NIGHTMARE 195 0.0056
829 BLOOD POTASSIUM DECREASED 166 0.0055
830 BREAST CANCER FEMALE 147 0.0055
831 RETCHING 117 0.0055
832 BLOOD CREATINE PHOSPHOKINASE INCREASED 157 0.0054
833 METABOLIC ACIDOSIS 174 0.0054
834 EYE SWELLING 202 0.0054
835 PNEUMOTHORAX 86 0.0054
836 CHROMATURIA 122 0.0054
837 NOCTURIA 65 0.0053
838 THERAPY PARTIAL RESPONDER 83 0.0053
839 ABDOMINAL PAIN LOWER 133 0.0053
840 EYE PAIN 295 0.0052
841 LIP SWELLING 174 0.0052
842 TREATMENT NONCOMPLIANCE 285 0.0052
843 DYSPNOEA EXERTIONAL 195 0.0052
844 CYTOMEGALOVIRUS INFECTION 86 0.0052
845 OCULAR HYPERAEMIA 243 0.0051
846 SOMNOLENCE 1028 0.0051
847 HOSPITALISATION 784 0.0051
848 INTRAOCULAR PRESSURE INCREASED 65 0.0051
849 MUCOSAL INFLAMMATION 132 0.0050
850 HYPERSOMNIA 144 0.0050
851 CHEST DISCOMFORT 512 0.0050
852 DYSPHAGIA 471 0.0050
853 URINARY INCONTINENCE 146 0.0049
854 TRANSIENT ISCHAEMIC ATTACK 166 0.0049
855 BLOOD SODIUM DECREASED 92 0.0049
856 CARDIAC FAILURE 390 0.0049
857 THROAT TIGHTNESS 131 0.0048
858 THIRST 86 0.0048
859 FOETAL EXPOSURE DURING PREGNANCY 391 0.0048
860 INCORRECT PRODUCT ADMINISTRATION DURATION 104 0.0048
861 BALANCE DISORDER 413 0.0048
862 PRESYNCOPE 116 0.0048
863 MOOD ALTERED 130 0.0048
864 CORONARY ARTERY OCCLUSION 65 0.0047
865 DRUG DOSE OMISSION 777 0.0047
866 HEART RATE DECREASED 164 0.0047
867 DRUG INTERACTION 734 0.0046
868 PULMONARY OEDEMA 207 0.0046
869 CARDIAC FAILURE CONGESTIVE 371 0.0046
870 MOOD SWINGS 147 0.0046
871 CARDIOMYOPATHY 68 0.0046
872 LYMPHOPENIA 65 0.0046
873 SKIN FISSURES 89 0.0045
874 LACRIMATION INCREASED 137 0.0045
875 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 816 0.0045
876 BREAST CANCER 419 0.0045
877 VISION BLURRED 607 0.0044
878 ANAPHYLACTIC SHOCK 113 0.0044
879 ANGINA PECTORIS 125 0.0044
880 TREMOR 724 0.0044
881 DYSGEUSIA 321 0.0043
882 THERAPEUTIC RESPONSE SHORTENED 143 0.0043
883 DEATH 3618 0.0042
884 EYE PRURITUS 140 0.0042
885 PAIN OF SKIN 112 0.0042
886 BLOOD ALKALINE PHOSPHATASE INCREASED 103 0.0041
887 ABASIA 102 0.0041
888 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 139 0.0041
889 RENAL FAILURE 546 0.0041
890 SYNCOPE 410 0.0041
891 GAMMA-GLUTAMYLTRANSFERASE INCREASED 90 0.0041
892 PROCEDURAL PAIN 112 0.0040
893 COLD SWEAT 71 0.0040
894 ACUTE MYOCARDIAL INFARCTION 118 0.0040
895 SENSORY DISTURBANCE 64 0.0040
896 PERICARDIAL EFFUSION 91 0.0039
897 AGEUSIA 98 0.0039
898 COGNITIVE DISORDER 183 0.0039
899 UNEVALUABLE EVENT 296 0.0039
900 LETHARGY 223 0.0039
901 INTESTINAL OBSTRUCTION 146 0.0039
902 HAEMOPTYSIS 106 0.0038
903 PLATELET COUNT DECREASED 403 0.0038
904 ERUCTATION 73 0.0038
905 ARRHYTHMIA 177 0.0037
906 DIABETES MELLITUS INADEQUATE CONTROL 66 0.0037
907 GLYCOSYLATED HAEMOGLOBIN INCREASED 92 0.0036
908 BLOOD GLUCOSE ABNORMAL 67 0.0036
909 CHRONIC KIDNEY DISEASE 271 0.0036
910 EYE IRRITATION 205 0.0036
911 OXYGEN SATURATION DECREASED 200 0.0036
912 OSTEONECROSIS 116 0.0035
913 PULMONARY HYPERTENSION 70 0.0034
914 DEHYDRATION 447 0.0033
915 FEAR 90 0.0033
916 MUSCLE TWITCHING 77 0.0033
917 DISEASE PROGRESSION 392 0.0033
918 SKIN EXFOLIATION 277 0.0033
919 DIPLOPIA 85 0.0033
920 FULL BLOOD COUNT DECREASED 65 0.0032
921 EXPIRED PRODUCT ADMINISTERED 107 0.0032
922 DISTURBANCE IN ATTENTION 173 0.0032
923 CARDIOVASCULAR DISORDER 81 0.0032
924 SUICIDE ATTEMPT 193 0.0032
925 PRURITUS GENERALISED 68 0.0031
926 HAEMATEMESIS 79 0.0031
927 PANIC ATTACK 113 0.0031
928 NO ADVERSE EVENT 561 0.0031
929 OVERDOSE 659 0.0031
930 DRY SKIN 382 0.0029
931 HAEMATOMA 74 0.0029
932 INTENTIONAL OVERDOSE 183 0.0029
933 MULTIPLE SCLEROSIS 135 0.0028
934 RESPIRATORY FAILURE 203 0.0028
935 IRRITABILITY 166 0.0028
936 ACUTE KIDNEY INJURY 422 0.0028
937 HYPOTENSION 552 0.0027
938 DRUG DEPENDENCE 437 0.0027
939 BLOOD GLUCOSE INCREASED 505 0.0027
940 VISUAL ACUITY REDUCED 88 0.0026
941 NEUTROPENIA 357 0.0026
942 APHASIA 77 0.0025
943 PANCYTOPENIA 141 0.0025
944 BLOOD GLUCOSE DECREASED 120 0.0025
945 GASTRIC CANCER 63 0.0025
946 BLOOD PRESSURE DECREASED 164 0.0025
947 PANCREATIC CARCINOMA 70 0.0024
948 SEIZURE 279 0.0024
949 CORONARY ARTERY DISEASE 70 0.0023
950 MULTIPLE ORGAN DYSFUNCTION SYNDROME 65 0.0023
951 FLUSHING 232 0.0023
952 HAEMATURIA 78 0.0023
953 GASTROINTESTINAL HAEMORRHAGE 188 0.0022
954 SUICIDAL IDEATION 201 0.0022
955 MYELOSUPPRESSION 79 0.0022
956 RESTLESSNESS 80 0.0022
957 HEPATIC FUNCTION ABNORMAL 81 0.0022
958 DISORIENTATION 84 0.0021
959 ANGER 71 0.0021
960 INJECTION SITE RASH 64 0.0021
961 ANGIOEDEMA 90 0.0020
962 INJECTION SITE BRUISING 159 0.0020
963 CEREBRAL HAEMORRHAGE 70 0.0020
964 EXTRA DOSE ADMINISTERED 78 0.0019
965 WITHDRAWAL SYNDROME 80 0.0019
966 INJECTION SITE ERYTHEMA 231 0.0019
967 NEUTROPHIL COUNT DECREASED 73 0.0018
968 DYSARTHRIA 67 0.0018
969 PROSTATE CANCER 136 0.0017
970 INJECTION SITE PRURITUS 113 0.0017
971 COMA 79 0.0017
972 INJECTION SITE SWELLING 125 0.0016
973 HYPONATRAEMIA 90 0.0016
974 SKIN IRRITATION 72 0.0016
975 TOXICITY TO VARIOUS AGENTS 260 0.0015
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 306 0.0015
977 CARDIAC ARREST 120 0.0015
978 SKIN BURNING SENSATION 102 0.0014
979 BLADDER CANCER 80 0.0014
980 RENAL CANCER 64 0.0013
981 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 93 0.0013
982 BRADYCARDIA 67 0.0013
983 AGITATION 87 0.0012
984 INCORRECT DOSE ADMINISTERED 246 0.0011
985 INJECTION SITE PAIN 314 0.0010
986 EMOTIONAL DISTRESS 112 0.0009
987 HALLUCINATION 65 0.0009
988 PRODUCT STORAGE ERROR 75 0.0009